CompletedNot Applicable

Comparing Posterior Release Sclerotomy With Conventional Evisceration Surgery.

Egypt80 participantsStarted 2024-05-01

Plain-language summary

The primary objective of this interventional study is to compare posterior release sclerotomy in the scleral cup with conventional ball implantation during evisceration, focusing on intraoperative feasibility, postoperative outcomes, and implant stability. Specific objectives include: 1. Assessing the rate of implant migration and extrusion. 2. Evaluating the long-term stability of the implant within the scleral shell. 3. Investigating the occurrence of complications such as exposure or infection. 4. Analyzing the functional and anatomical outcomes. 5. Comparing patient satisfaction and quality of life measures.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 18 years or older * Indication for evisceration due to a non-malignant cause, such as painful blind eye, severe ocular trauma, end-stage glaucoma, or phthisis bulbi * Adequate scleral integrity to allow for ball implantation * No history of previous intraocular surgery or scleral weakening disorders Exclusion Criteria: * Orbital malignancy or suspected intraocular tumor * Active ocular or periocular infection * History of radiation therapy to the orbit * Severe scleral thinning that contraindicates scleral preservation * Presence of autoimmune disease affecting wound healing * Psychiatric disorders affecting compliance with postoperative care

What they're measuring

• Implant extrusion/migration rate within 6 months

Timeframe: Through study completion, an average of 6 months

Trial details

NCT IDNCT06962384

SponsorFayoum University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-28

View on ClinicalTrials.gov More Evisceration trials